Two-phase designs for biomarker studies when disease processes are under intermittent observation
Authors:
Open Access
- 9 April 2026
- journal article
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 82 (2)
Abstract
Multistate models offer an appealing framework for studying the onset and progression of chronic diseases in large cohort studies. Such studies often involve the collection and storage of biospecimens at an initial assessment, and intermittent observation of the disease process at future assessment times. We consider the design of two-phase biomarker studies in such settings where budgetary constraints prohibit assaying all biospecimens. A subsample of individuals is instead chosen to have their biospecimens assayed to facilitate examination of the association between a biomarker of interest and the disease process. Analyses based on likelihood, conditional likelihood, and estimating functions are considered, with the efficiency gains from various subsampling strategies investigated. Pseudo-score residual-dependent sampling strategies are shown to yield highly efficient maximum likelihood estimates of biomarker effects on disease progression. This sampling strategy along with competing methods are empirically studied and applied to a motivating study of the relationship between the HLA-B27 marker and joint damage in patients with psoriatic arthritis.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-04207)
- University of Waterloo
This publication has 27 references indexed in Scilit:
- Two‐phase designs with current status dataStatistics in Medicine, 2023
- Optimal sampling for design‐based estimators of regression modelsStatistics in Medicine, 2022
- Optimal Designs of Two-Phase StudiesJournal of the American Statistical Association, 2019
- Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time dataLifetime Data Analysis, 2019
- Two-phase outcome-dependent studies for failure times and testing for effects of expensive covariatesLifetime Data Analysis, 2016
- Adaptive sampling in two‐phase designs: a biomarker study for progression in arthritisStatistics in Medicine, 2015
- What makes UK Biobank special?The Lancet, 2012
- Improving power and robustness for detecting genetic association with extreme-value sampling designGenetic Epidemiology, 2011
- On the Two Different Aspects of the Representative Method: the Method of Stratified Sampling and the Method of Purposive Selection1992
- The Analysis of Panel Data under a Markov AssumptionJournal of the American Statistical Association, 1985